You have 9 free searches left this month | for more free features.

adult giant cell glioblastoma

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Burkitt Lymphoma, KSHV-associated Multicentric Castleman Disease, DLBCL Trial in Kampala (Rituximab and Hyaluronidase Human,

Recruiting
  • Burkitt Lymphoma
  • +2 more
  • Rituximab and Hyaluronidase Human
  • +8 more
  • Kampala, Uganda
    UCI-Fred Hutch Cancer Centre
Mar 9, 2022

Baylor Infant and Toddler Biomarker of Nutrition Study

Not yet recruiting
  • Healthy Nutrition
  • Healthy Diet
  • Carotenoid Intake
  • Serum carotenoid concentrations
  • Houston, Texas
    USDA/ARS Children's Nutrition Research Center, Baylor College of
May 12, 2023

Bacterial Vaginosis Trial in Sweden (pHyph)

Not yet recruiting
  • Bacterial Vaginosis
  • pHyph
  • Linköping, Sweden
  • +3 more
Nov 7, 2023

PFS Trial in Qingdao (afatinib)

Recruiting
  • PFS
  • Qingdao, Shandong, China
  • +1 more
Feb 23, 2022

Head Neck Cancer, Locally Advanced Trial in Bangkok (Palbociclib, Cetuximab, Intensity Modulated Radiation Therapy)

Active, not recruiting
  • Head and Neck Cancer
  • Locally Advanced
  • Bangkok, Thailand
    Faculty of Medicine, Ramathibodi Hospital
Sep 19, 2022

Sickle Cell Disease, Vaso-occlusive Pain Episode in Sickle Cell Disease Trial in Bruxelles (Clonidine)

Recruiting
  • Sickle Cell Disease
  • Vaso-occlusive Pain Episode in Sickle Cell Disease
  • Bruxelles, Belgium
    CHU Saint-Pierre
May 5, 2023

Smoking, Tobacco Trial in Tulsa (Physician Sent Outreach with Embedded Asynchronous Care in Portal Message, Physician Sent

Completed
  • Smoking, Tobacco
  • Physician Sent Outreach with Embedded Asynchronous Care in Portal Message
  • +3 more
  • Tulsa, Oklahoma
    Oklahoma State University Center for Health Sciences
Dec 28, 2021

Depression Trial in Hanoi (Supported Self-Management, Enhanced treatment as usual)

Completed
  • Depression
  • Supported Self-Management
  • Enhanced treatment as usual
  • Hanoi, Vietnam
    Institute of Population, Health and Development
May 26, 2022

HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,

Recruiting
  • HIV Infection
  • +10 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • La Jolla, California
  • +3 more
Dec 7, 2022

Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Cryoablation
  • Cryoablation combined with PD1 Inhibitor
  • (no location specified)
Mar 28, 2023

Patients With Cancer Undergoing Radiation Therapy

Terminated
  • Malignant Neoplasm
  • cytology specimen collection procedure
  • laboratory biomarker analysis
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Aug 15, 2022

Oncology, NSCLC Stage IV, NSCLC, Stage III Trial in Drammen (UV1, Sagramostim, Anti-PD-1/PD-L1 treatment)

Recruiting
  • Oncology
  • +2 more
  • UV1
  • +2 more
  • Drammen, Viken, Norway
    Vestre Viken Health Trust
Aug 15, 2022

Chronic Granulomatous Disease, CGD Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (JSP191)

Recruiting
  • Chronic Granulomatous Disease
  • CGD
  • JSP191
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 5, 2023

Tobacco Use Disorder Trial in Charleston, Pickens (Varenicline, Contingency Management, Counseling)

Recruiting
  • Tobacco Use Disorder
  • Charleston, South Carolina
  • +1 more
Jan 12, 2022

Advanced Malignant Solid Tumor, Clinical Stage III Gastroesophageal Junction Adenocarcinoma, Clinical Stage IV Gastroesophageal

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +28 more
  • Trifluridine and Tipiracil Hydrochloride
  • Talazoparib Tosylate
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 2, 2022

Blood Flow Restriction, ACL Tear, ACL Injury Trial in Farmington (Blood Flow Restriction using Delfi Personalized Tourniquet

Active, not recruiting
  • Blood Flow Restriction
  • +2 more
  • Blood Flow Restriction using Delfi Personalized Tourniquet System
  • Farmington, Connecticut
    Connecticut Children's Sports Physical Therapy
Mar 30, 2022

NSCLC Trial in Guangzhou (Savolitinib, Placebo)

Recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, China
    Guangdong General Hospital
Nov 29, 2021

Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck Trial (enoblituzumab, MGA012, MGD013)

Withdrawn
  • Head and Neck Cancer
  • Squamous Cell Carcinoma of Head and Neck
  • enoblituzumab
  • +2 more
  • (no location specified)
Feb 4, 2022

Stroke Trial in Peshawar (kinesiotaping, motor relearning program)

Recruiting
  • Stroke
  • kinesiotaping
  • motor relearning program
  • Peshawar, Pakistan
    Rehman Medical Institute
Dec 9, 2022

Chromosomal Instability in Early Diagnosis of Biliary Tract

Recruiting
  • Biliary Tract Carcinoma
  • The extracted DNA from bile samples will be analyzed by BileCAD to determine the level of CIN.
  • Taizhou, Zhejiang, China
    Taizhou Hospital of Zhejiang Province
Apr 25, 2023

Hematologic Malignancies Trial in Hangzhou (RD13-01 cell infusion)

Completed
  • Hematologic Malignancies
  • RD13-01 cell infusion
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital,College of Medicine, Zhejiang Univ
Jan 8, 2022

Spinal Muscular Atrophy Trial in Worldwide

Not yet recruiting
  • Spinal Muscular Atrophy
    • Buenos Aires, Caba, Argentina
    • +20 more
    Jul 24, 2022

    Stereotactic Margins in Localized Bronchial Cancer (T1/T2a, N0)

    Recruiting
    • Bronchial Cancer
      • Strasbourg, France
        Service de chirurgie thoracique - CHU de Strasbourg - France
      Oct 28, 2022

      Peripheral T-Cell Lymphoma Trial in Zhengzhou (Parsaclisib, Chidamide)

      Not yet recruiting
      • Peripheral T-Cell Lymphoma
      • Zhengzhou, Henan, China
        Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
      Dec 26, 2021

      Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia Not Having Achieved Remission, Acute Lymphoblastic

      Unknown status
      • Acute Lymphoblastic Leukemia, in Relapse
      • +2 more
      • CD19-CAR-T2 Cells
      • Guangzhou, Guangdong, China
        Nanfang Hospital, Southern Medical University
      Oct 25, 2020